Treatment of a persistent postoperative chylothorax with somatostatin

P C Rimensberger1, B Müller-Schenker, A Kalangos

  • 1Department of Pediatrics, Hôpital des Enfants, University Hospital of Geneva, Switzerland. rimensberger-peter@hcuge.ch

Insights

A persistent chylothorax in an infant after heart surgery was successfully treated with somatostatin infusion. This treatment reduced chyle production, enabling early feeding and avoiding further surgery.

Area of Science:

  • Pediatric Cardiac Surgery
  • Thoracic Complications
  • Gastroenterology

Background:

  • Chylothorax is a rare, serious complication following pediatric cardiac operations.
  • D-transposition of the great vessels requires complex surgical correction, such as the Senning procedure.
  • Persistent chylothorax can lead to malnutrition and prolonged hospitalization.

Observation:

  • A 4-month-old infant developed persistent chylothorax post-Senning procedure for D-transposition of the great vessels.
  • Conservative management including 3 weeks of continuous drainage was ineffective.
  • The infant required an alternative treatment to manage the chyle leak.

Findings:

  • Continuous somatostatin infusion for 14 days effectively reduced and stopped chyle production.
  • Somatostatin therapy facilitated the resumption of early enteral feeding.
  • This non-surgical approach successfully resolved the chylothorax.

Implications:

  • Somatostatin infusion represents a viable therapeutic option for managing persistent postoperative chylothorax in pediatric cardiac surgery patients.
  • Early enteral feeding can be resumed, improving nutritional status and patient outcomes.
  • This approach may prevent the need for further invasive surgical interventions.